Obalon Therapeutics OBLN shares spiked about 30 percent following circulation of a Food and Drug Administration AccessData.gov document for the weight loss Obalon balloon system.
The Obalon Balloon System is a swallowable intragastric balloon system indicated for temporary use to facilitate weight loss in adults with obesity.
Obalon Therapeutics traded at $1.47 per share at time of publication, up 12 percent.
Related Link:
Obalon Closes Above $1 Following Questionable Takeover Rumor
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted In:
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
